Literature DB >> 176961

Cyclic adenosinemonophosphate in cerebrospinal fluid. Effects of theophylline, L-dopa and a dopamine receptor stimulant in rats.

M Kiessling, T Lindl, H Cramer.   

Abstract

The effects of L-Dopa and the dopamine receptor stimulant ET-495 on cisternal cAMP levels were studied in rats. L-dopa (100-200 mg/kg) increased cisternal cAMP levels by 60 to 80% of controls. When peripheral Dopa-decarboxylase was inhibited, smaller doses of L-Dopa were effective. Fla-63, an inhibitor of dopamine-beta-hydroxylase lowered the increase induced by L-Dopa which was completely suppressed by propranolol, not by phentolamine, suggesting that the cAMP increase is mediated through a central beta-adrenoceptor stimulation. ET-495 failed to influence cAMP levels which argues against a dopamine-sensitive adenylate cyclase involved in the L-Dopa effect. Moreover, large increases of cisternal cAMP were observed after treatment with theophylline , not papaverine which suggests different effects of these "phosphodiesterase inhibitors" on the cyclic AMP systems in the central nervous system or on transport mechanisms.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 176961     DOI: 10.1007/bf00342062

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  22 in total

1.  Evidence against dopamine as the mediator of the rise of cyclic AMP in the superior cervical ganglion of the rat.

Authors:  T Lindl; H Cramer
Journal:  Biochem Biophys Res Commun       Date:  1975-07-22       Impact factor: 3.575

2.  L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

Authors:  G M Everett; J W Borcherding
Journal:  Science       Date:  1970-05-15       Impact factor: 47.728

3.  Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.

Authors:  H Cramer; L K Ng; T N Chase
Journal:  Arch Neurol       Date:  1973-09

4.  Accumulation of adenosine 3',5'-monophosphate induced by catecholamines in the rat superior cervical ganglion in vitro.

Authors:  H Cramer; D G Johnson; I Hanbauer; S D Silberstein; I J Kopin
Journal:  Brain Res       Date:  1973-04-13       Impact factor: 3.252

5.  Effect of probenecid on levels of cyclic AMP in human cerebrospinal fluid.

Authors:  H Cramer; L K Ng; T N Chase
Journal:  J Neurochem       Date:  1972-06       Impact factor: 5.372

6.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

7.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

8.  Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid.

Authors:  F A Gerbode; M B Bowers
Journal:  J Neurochem       Date:  1968-09       Impact factor: 5.372

Review 9.  The mechanisms of action of L-dopa in Parkinson's disease.

Authors:  O Hornykiewicz
Journal:  Life Sci       Date:  1974-10-01       Impact factor: 5.037

10.  Cyclic adenosine monophosphate: selective increase in caudate nucleus after administration of L-dopa.

Authors:  E Garelis; N H Neff
Journal:  Science       Date:  1974-02-08       Impact factor: 47.728

View more
  2 in total

1.  The effect of L-dopa and propranolol on human CSF cyclic nucleotides.

Authors:  R H Belmaker; R P Ebstein; J Biederman; R Stern; M Berman; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

2.  The effects of probenecid on cyclic adenosine 3',5'-monophosphate levels in cerebrospinal fluid and on brain phosphodiesterase activity in the rat.

Authors:  R Horstmann; R Hammers; P Clarenbach; H Cramer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.